Prevalence and clinical implication of metabolic syndrome in chronic heart failure - Report from MetS-CHF study

Circulation Journal

Volumn 74, Issue 12, 2010, Pages 2612-2621

  Miura, Yutaka ^a   Fukumoto, Yoshihiro ^a   Shiba, Nobuyuki ^a   Miura, Toshiro ^b   Shimada, Kazunori ^c   Iwama, Yoshitaka ^c   Takagi, Atsutoshi ^c   Matsusaka, Hidenori ^d   Tsutsumi, Takaki ^d   Yamada, Akira ^d   Kinugawa, Shintaro ^e   Asakura, Masanori ^f   Okamatsu, Shuichi ^d   Tsutsui, Hiroyuki ^e   Daida, Hiroyuki ^c   Matsuzaki, Masunori ^b   Tomoike, Hitonobu ^f   Shimokawa, Hiroaki ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d ASO IIZUKA HOSPITAL   (Japan)

^e HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Chronic heart failure; Metabolic syndrome; Obesity; Sex

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CIGARETTE SMOKING; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; DYSLIPIDEMIA; FEMALE; GLUCOSE INTOLERANCE; HEART EJECTION FRACTION; HEART FAILURE; HEART RATE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; JAPAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PREVALENCE; SEX DIFFERENCE; WAIST CIRCUMFERENCE;

AGE FACTORS; AGED; ALCOHOL DRINKING; CHRONIC DISEASE; FEMALE; HEART FAILURE; HUMANS; JAPAN; MALE; METABOLIC SYNDROME X; PREVALENCE; SEX FACTORS; SMOKING; STROKE VOLUME;

EID: 78649698402     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-10-0677     Document Type: Article

References (39)

1. Matsushita Y, Takahashi Y, Mizoue T, Inoue M, Noda M, Tsugane S. Overweight and obesity trends among Japanese adults: A 10- year follow-up of the JPHC Study. Int J Obes (Lond) 2008; 32: 1861-1867.
2. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120: 1640-1645.
3. Ninomiya T, Kubo M, Doi Y, Yonemoto K, Tanizaki Y, Rahman M, et al. Impact of metabolic syndrome on the development of cardiovascular disease in a general Japanese population: The Hisayama study. Stroke 2007; 38: 2063-2069.
4. Kokubo Y, Okamura T, Yoshimasa Y, Miyamoto Y, Kawanishi K, Kotani Y, et al. Impact of metabolic syndrome components on the incidence of cardiovascular disease in a general urban Japanese population: The suita study. Hypertens Res 2008; 31: 2027-2035.
5. Kato M, Dote K, Sasaki S, Ueda K, Matsuda O, Nakano Y, et al. Coronary plaque vulnerability in metabolic syndrome: Assessment of carotid artery morphology in acute coronary syndrome. Circ J 2007; 71: 1229-1233.
6. Kajimoto K, Kasai T, Miyauchi K, Hirose H, Yanagisawa N, Yamamoto T, et al. Metabolic syndrome predicts 10-year mortality in non-diabetic patients following coronary artery bypass surgery. Circ J 2008; 72: 1481-1486.
7. Niwa Y, Ishikawa S, Gotoh T, Kayaba K, Nakamura Y, Kajii E. Association Between Stroke and Metabolic Syndrome in a Japanese Population: Jichi Medical School (JMS) Cohort Study. J Epidemiol 2010; 20: 62-69.
8. Dohi T, Miyauchi K, Kasai T, Kajimoto K, Kubota N, Tamura H, et al. Impact of metabolic syndrome on 10-year clinical outcomes among patients with acute coronary syndrome. Circ J 2009; 73: 1454-1458.
9. Higashiyama A, Okamura T, Ono Y, Watanabe M, Kokubo Y, Okayama A. Risk of smoking and metabolic syndrome for incidence of cardiovascular disease: Comparison of relative contribution in urban Japanese population: The Suita study. Circ J 2009; 73: 2258-2263.
10. Suzuki T, Katz R, Jenny NS, Zakai NA, LeWinter MM, Barzilay JI, et al. Metabolic syndrome, inflammation, and incident heart failure in the elderly: The cardiovascular health study. Circ Heart Fail 2008; 1: 242-248.
11. Tamariz L, Hassan B, Palacio A, Arcement L, Horswell R, Hebert K. Metabolic syndrome increases mortality in heart failure. Clin Cardiol 2009; 32: 327-331.
12. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, et al. 2009 focused update incorporated into the ACC/ AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 2009; 119: e391-e479.
13. Kitzman DW, Little WC, Brubaker PH, Anderson RT, Hundley WG, Marburger CT, et al. Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure. JAMA 2002; 288: 2144-2150.
14. Redfield MM, Jacobsen SJ, Burnett JC Jr, Mahoney DW, Bailey KR, Rodeheffer RJ. Burden of systolic and diastolic ventricular dysfunction in the community: Appreciating the scope of the heart failure epidemic. JAMA 2003; 289: 194-202.
15. Cleland JG, Cohen-Solal A, Aguilar JC, Dietz R, Eastaugh J, Follath F, et al. Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): An international survey. Lancet 2002; 360: 1631-1639.
16. Bhatia RS, Tu JV, Lee DS, Austin PC, Fang J, Haouzi A, et al. Outcome of heart failure with preserved ejection fraction in a population- based study. N Engl J Med 2006; 355: 260-269.
17. Paulus WJ, Tschope C, Sanderson JE, Rusconi C, Flachskampf FA, Rademakers FE, et al. How to diagnose diastolic heart failure: A consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 2007; 28: 2539-2550.
18. Ohnishi H, Saitoh S, Akasaka H, Mitsumata K, Chiba M, Furugen M, et al. Incidence of hypertension in individuals with abdominal obesity in a rural Japanese population: The Tanno and Sobetsu study. Hypertens Res 2008; 31: 1385-1390.
19. Hata J, Doi Y, Ninomiya T, Tanizaki Y, Yonemoto K, Fukuhara M, et al. The effect of metabolic syndrome defined by various criteria on the development of ischemic stroke subtypes in a general Japanese population. Atherosclerosis 2010; 210: 249-255.
20. Kobayashi J, Nishimura K, Matoba M, Maekawa N, Mabuchi H. Generation and gender differences in the components contributing to the diagnosis of the metabolic syndrome according to the Japanese criteria. Circ J 2007; 71: 1734-1737.
21. Sarzani R, Salvi F, Dessi-Fulgheri P, Rappelli A. Renin-angiotensin system, natriuretic peptides, obesity, metabolic syndrome, and hypertension: An integrated view in humans. J Hypertens 2008; 26: 831-843.
22. Hoshino A, Nakamura T, Enomoto S, Kawahito H, Kurata H, Nakahara Y, et al. Prevalence of coronary artery disease in Japanese patients with cerebral infarction: Impact of metabolic syndrome and intracranial large artery atherosclerosis. Circ J 2008; 72: 404-408.
23. Nakata S, Tsutsui M, Shimokawa H, Suda O, Morishita T, Shibata K, et al. Spontaneous myocardial infarction in mice lacking all nitric oxide synthase isoforms. Circulation 2008; 117: 2211-2223.
24. Baba R, Koketsu M, Nagashima M, Inasaka H, Yoshinaga M, Yokota M. Adolescent obesity adversely affects blood pressure and resting heart rate. Circ J 2007; 71: 722-726.
25. Yamamoto K, Redfield MM, Nishimura RA. Analysis of left ventricular diastolic function. Heart 1996; 75: 27-35.
26. Fukumoto Y, Libby P, Rabkin E, Hill CC, Enomoto M, Hirouchi Y, et al. Statins alter smooth muscle cell accumulation and collagen content in established atheroma of watanabe heritable hyperlipidemic rabbits. Circulation 2001; 103: 993-999.
27. Waseda K, Ozaki Y, Takashima H, Ako J, Yasukawa T, Ismail TF, et al. Impact of angiotensin II receptor blockers on the progression and regression of coronary atherosclerosis: An intravascular ultrasound study. Circ J 2006; 70: 1111-1115.
28. Fukui S, Fukumoto Y, Suzuki J, Saji K, Nawata J, Shinozaki T, et al. Diabetes mellitus accelerates left ventricular diastolic dysfunction through activation of the renin-angiotensin system in hypertensive rats. Hypertens Res 2009; 32: 472-480.
29. Vanhoutte PM, Shimokawa H, Tang EH, Feletou M. Endothelial dysfunction and vascular disease. Acta Physiol (Oxf) 2009; 196: 193-222.
30. Komatsu H, Yamada S, Iwano H, Okada M, Onozuka H, Mikami T, et al. Angiotensin II receptor blocker, valsartan, increases myocardial blood volume and regresses hypertrophy in hypertensive patients. Circ J 2009; 73: 2098-2103.
31. Nozue T, Yamamoto S, Tohyama S, Umezawa S, Kunishima T, Sato A, et al. Treatment with statin on atheroma regression evaluated by intravascular ultrasound with Virtual Histology (TRUTH Study): Rationale and design. Circ J 2009; 73: 352-355.
32. Matsumoto Y, Adams V, Jacob S, Mangner N, Schuler G, Linke A. Regular exercise training prevents aortic valve disease in lowdensity lipoprotein-receptor-deficient mice. Circulation 2010; 121: 759-767.
33. Libby P, Okamoto Y, Rocha VZ, Folco E. Inflammation in atherosclerosis: Transition from theory to practice. Circ J 2010; 74: 213-220.
34. Zhao Y, Fukumoto Y, Mohri M, Shimokawa H, Takeshita A. Impact of sex and age on coronary basal tone. Intern Med 2005; 44: 354-355.
35. Shaw LJ, Bugiardini R, Merz CN. Women and ischemic heart disease: Evolving knowledge. J Am Coll Cardiol 2009; 54: 1561-1575.
36. Velagaleti RS, Massaro J, Vasan RS, Robins SJ, Kannel WB, Levy D. Relations of lipid concentrations to heart failure incidence: The Framingham Heart Study. Circulation 2009; 120: 2345-2351.
37. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497.
38. Pasternak RC, Smith SC Jr, Bairey-Merz CN, Grundy SM, Cleeman JI, Lenfant C. ACC/AHA/NHLBI Clinical Advisory on the Use and Safety of Statins. Circulation 2002; 106: 1024-1028.
39. Alberti KG, Zimmet P, Shaw J. The metabolic syndrome: A new worldwide definition. Lancet 2005; 366: 1059-1062.